Children's Hospital of Philadelphia

Mastery Schools, Children's Hospital of Philadelphia Announce Innovative Healthcare High School to Address Local Healthcare Workforce Shortages with Support from Bloomberg Philanthropies

Retrieved on: 
금요일, 4월 5, 2024
Automation, TIA, Growth, Health, CHOP, Partnership, Education, School, Knowledge, Bureau, Bloomberg L.P., Comp, Poverty, Student, Bloomberg Philanthropies, Hospital, Workforce, Dream, Children's Hospital of Philadelphia, Nursing

PHILADELPHIA, April 5, 2024 /PRNewswire/ -- Children's Hospital of Philadelphia (CHOP) and Mastery Schools announced today an unprecedented partnership to design a high school that will help prepare students for well-paying careers in healthcare and address local education and healthcare talent needs. Through this initiative from Bloomberg Philanthropies, Mastery Hardy Williams High School will be revamped to fully integrate healthcare career knowledge and job-training with a high-quality, well-rounded high school experience for students in Philadelphia, graduating students directly into high-demand healthcare jobs at CHOP with family-sustaining wages.

Key Points: 
  • Through this initiative from Bloomberg Philanthropies , Mastery Hardy Williams High School will be revamped to fully integrate healthcare career knowledge and job-training with a high-quality, well-rounded high school experience for students in Philadelphia, graduating students directly into high-demand healthcare jobs at CHOP with family-sustaining wages.
  • "By combining classroom learning with hands-on experience, these specialized health-care high schools will prepare students for careers with opportunities for growth and advancement.
  • Despite inflation, the labor market remains incredibly competitive, with shortages in every area from direct patient care to healthcare operations to administration.
  • Bloomberg Philanthropies' investment will support school start-up costs including personnel needs, classroom and lab renovations, and other work-based learning requirements.

Orchard Therapeutics Outlines U.S. Launch Plans for Lenmeldy™ (atidarsagene autotemcel), the Only Approved Therapy for Children with Early-onset Metachromatic Leukodystrophy

Retrieved on: 
수요일, 3월 20, 2024
Encephalitis, ICER, Bone marrow, Patient, DSM-IV codes, Urinary tract infection, Travel, Child, Health technology assessment, Therapy, Children's Hospital of Philadelphia, Central nervous system, Risk, MLD, Qualification, Health, WAC, NBS, Nerve, Mutation, UCSF, Disease, Federation, Research, Acquisition, Genome, Rash, Stem cell, HSC, Hospital, Family, Swelling, FDA, Diagnosis, HTA, Caregiver, Traffic barrier, Viral, Fever, Kyowa Kirin, PSLI, Liver, Government, San Raffaele Hospital, ARSA, Pharmaceutical industry

TOKYO, LONDON and BOSTON, March 20, 2024 (GLOBE NEWSWIRE) -- Orchard Therapeutics, recently acquired by Kyowa Kirin with the goal of accelerating the delivery of new gene therapies to patients around the globe, today announced the details of its U.S. commercial launch of Lenmeldy™ (atidarsagene autotemcel), formerly known as OTL-200, the first FDA-approved therapy for the treatment of children with pre-symptomatic late infantile (PSLI), pre-symptomatic early juvenile, (PSEJ), or early symptomatic early juvenile (ESEJ)—collectively referred to as early-onset—metachromatic leukodystrophy (MLD).

Key Points: 
  • Prior to Lenmeldy, there were no treatment options in the U.S. for early-onset MLD beyond supportive and end-of-life care.
  • This approach has the potential to restore enzymatic function to stop or slow disease progression with a single treatment.
  • Utilizing results from such studies, a multi-stakeholder working group is finalizing a nomination to add MLD to the U.S.
  • Based on current timelines and assumptions, Orchard Therapeutics expects the nomination will be submitted in mid-year 2024.

Children's Hospital of Philadelphia's Richard D. Wood Jr. Center for Fetal Diagnosis and Treatment Earns Two Press Ganey Awards

Retrieved on: 
목요일, 3월 28, 2024
Surgeon, SDU, CHOP, Press Ganey Associates, Patient, Periodic function, Pinnacle, MD, Birth, Senior counsel, Hospital, Heart, Excellence, CFDT, Test management, Children's Hospital of Philadelphia, Parent, Nursing

PHILADELPHIA, March 28, 2024 /PRNewswire/ -- The Richard D. Wood Jr. Center for Fetal Diagnosis and Treatment (CFDT) at Children's Hospital of Philadelphia (CHOP) has once again received prestigious recognition from Press Ganey, a healthcare company that evaluates patient satisfaction.

Key Points: 
  • As in 2022, 2021 and 2020, the CFDT won the 2023 Pinnacle of Excellence Award®, a preeminent, competitive achievement for leading healthcare organizations.
  • Presented annually, the award applauds hospitals and health systems that consistently sustain performance year-over-year.
  • "This award underscores the team's dedication to keeping our patients and families at the forefront of every decision and treatment option."
  • The SDU is the world's first birth facility in a pediatric hospital specifically designed for healthy mothers carrying babies with known birth defects.

CHOP Researchers Find Branched Chain Amino Acid Supplementation May Aid in Concussion Recovery

Retrieved on: 
화요일, 3월 19, 2024
Online, Research, Mind, Stroke, Concussion, Assistant, CHOP, Critical Care Medicine (journal), Patient, DSM-IV codes, Journal, Anesthesiology, Leucine, Dana Foundation, Health, University, Doctor of Philosophy, MD, Human, Valine, Critical care, Adolescence, Isoleucine, Veteran, Clinical trial, BCAA, Pediatrics, Traumatic brain injury, National Institutes of Health, Hospital, Head injury, Randomized controlled trial, Safety, Ageing, HIT, Bangladesh Technical Education Board, Medicine, Children's Hospital of Philadelphia, MSCE, Dietary supplement

PHILADELPHIA, March 19, 2024 /PRNewswire/ -- In the first clinical trial of a targeted pharmacologic therapeutic for mild traumatic brain injury in pediatric patients, scientists from the Minds Matter Concussion Frontier Program at Children's Hospital of Philadelphia (CHOP) have found preliminary evidence that adolescents and young adults with concussion who take a specific formulation of branched chain amino acid (BCAA) supplements after injury experience faster symptom reduction and return to physical activity. The findings were published online by the Journal of Neurotrauma.

Key Points: 
  • The mainstay of treatment remains symptom management with temporary modification of cognitive and physical activity and over the counter medication.
  • Although active rehabilitation strategies have shown promise for improving recovery time, including aerobic, vestibular, and vision interventions, these can be time and labor intensive.
  • To date, no targeted pharmacologic intervention to improve clinical outcomes in concussion has been evaluated in humans.
  • However, prior to this study, no human studies involving adolescents and young adults have assessed the potential benefits of this formulation of BCAAs as a specific treatment to aid in concussion recovery.

St. Baldrick's Foundation Allocates $1.1 Million for Fellowships to Empower Emerging Childhood Cancer Researchers

Retrieved on: 
금요일, 3월 8, 2024
Neoplasm, Cancer, Survivor, Toxicity, Osteosarcoma, Immunotherapy, Children's Hospital of Philadelphia, University, University of California, Canadian Aviation Regulations, Hospital, Brain, Child, Food, Vaccine, Cell adhesion, Bone marrow, Dana–Farber Cancer Institute, Leukemia, Medicine, Baylor College of Medicine, Acute myeloid leukemia, Food security, Lymphoma, Research, Baylor University, Immune system

The St. Baldrick's Foundation granted over $1.1 million in Fellow awards to nurture emerging childhood cancer researchers dedicated to overcoming pediatric cancers.

Key Points: 
  • The St. Baldrick's Foundation granted over $1.1 million in Fellow awards to nurture emerging childhood cancer researchers dedicated to overcoming pediatric cancers.
  • The $1.1 million was distributed to seven researchers making strides in discovering new cures for pediatric cancers.
  • The St. Baldrick's Foundation 2024 Fellows are:
    Dr. Vanja Cabric at Memorial Sloan Kettering Cancer Center, New York, NY
    Hepatoblastoma, common in childhood, lacks effective immunotherapy due to limited understanding of pediatric immune response to tumors.
  • Since 2005, St. Baldrick's has granted more than $342 million to support the development of childhood cancer treatments that have the potential to impact every kid diagnosed with cancer.

The Wyss Foundation Provides $5 Million in Funding for Children's Hospital of Philadelphia's Wyss/Campbell Center for Thoracic Insufficiency Syndrome

Retrieved on: 
목요일, 2월 22, 2024
VEPTR, Division, Adrenal insufficiency, Algorithm, Spinal fusion, Spine, Education, MD, Children's Hospital of Philadelphia, Physician, FDA, Quality of life, 3D, Hospital, Surgeon, Health, Wyss, TIS, Patient, CHOP, Child, Wyss Foundation, Nursing

PHILADELPHIA, Feb. 22, 2024 /PRNewswire/ -- Children's Hospital of Philadelphia (CHOP) is thrilled to announce a gift of $5 million from the Wyss Foundation to support innovations that improve the lives of patients with thoracic insufficiency syndrome (TIS). An initial gift from Hansjörg Wyss, philanthropist and chairman of the Wyss Foundation, was made to CHOP in 2019 and honored the legacy of the late Dr. Robert Campbell, a world-renowned CHOP pediatric orthopaedic surgeon. Now, additional funding has renamed and established the Wyss/Campbell Center for Thoracic Insufficiency Syndrome, one of CHOP's frontier programs, a trailblazing group of initiatives pioneering new advances in children's health. 

Key Points: 
  • Now, additional funding has renamed and established the Wyss/Campbell Center for Thoracic Insufficiency Syndrome , one of CHOP's frontier programs, a trailblazing group of initiatives pioneering new advances in children's health.
  • The $5 million gift will ensure the Center, its clinical team, researchers and patients have the resources needed to thrive by amplifying studies, tools and education.
  • The Center will be named Wyss/Campbell Center for Thoracic Insufficiency Syndrome in perpetuity.
  • The Wyss Foundation is honored to support the team working to improve the quality of life for children living with TIS," said Molly McUsic, President of the Wyss Foundation.

New Resource for Selecting Best Treatment Path for Young Children with Cancerous Tumors Published by NCCN

Retrieved on: 
수요일, 2월 7, 2024
Concurrent estate, Toxicity, Survival, Hospital, Young adult, Child, Immunotherapy, Clinical trial, Children's Hospital of Philadelphia, Patient, NCCN, Brain, Chair, Diagnosis, Conference, Adolescence, Disease, Radiation, Cancer, Pediatrics

PLYMOUTH MEETING, Pa., Feb. 7, 2024 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—today published its first ever set of treatment recommendations pertaining to neuroblastoma. Neuroblastoma is a type of solid tumor cancer that typically occurs in early childhood, with the majority diagnosed before age five.1 Neuroblastoma is the most common type of solid tumor (outside of brain tumors) in children, with more than 700 cases diagnosed in the United States every year.2 Research innovations have led to survival rates that are better than 90% for patients with low- and intermediate-risk neuroblastoma and around 50% for those with high-risk disease.3 Improving outcomes for patients with high-risk neuroblastoma and reducing long-term treatment effects for all patients remain areas of active research.

Key Points: 
  • There are now 87 different NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), covering nearly every type of cancer, plus screening, prevention, and supportive care.
  • The NCCN Guidelines have a long history of providing treatment guidance that correlates with improved outcomes across numerous cancer types.
  • The NCCN Guidelines are intended as a resource for care providers and coverage determinations throughout the U.S. and around the world.
  • There are separate NCCN Guidelines for Survivorship that include additional information on mitigating the long-term impact of treatment.

Children's Hospital of Philadelphia Experts Showcase Frontier Program at Arab Health Exhibition

Retrieved on: 
월요일, 1월 29, 2024
Health care, Patient, Artery, Research, Chiari malformation, CHOP, Vein, Health, Arab Health, Partnership, Children's Hospital of Philadelphia, Malignancy, Business, Gravity anomaly, Glomus tumor, Congress, Hospital, Lymphatic system, Pain, EHS, Vascular anomaly, Deformity, Nursing

PHILADELPHIA, Jan. 29, 2024 /PRNewswire/ -- Showcasing its longstanding partnership with the United Arab Emirates (UAE) Emirates Health Services (EHS), Children's Hospital of Philadelphia (CHOP) will exhibit thought-leading clinical research in the EHS booth at the Arab Health 2024 Exhibition and Congress , taking place this week in Dubai.

Key Points: 
  • PHILADELPHIA, Jan. 29, 2024 /PRNewswire/ -- Showcasing its longstanding partnership with the United Arab Emirates (UAE) Emirates Health Services (EHS), Children's Hospital of Philadelphia (CHOP) will exhibit thought-leading clinical research in the EHS booth at the Arab Health 2024 Exhibition and Congress , taking place this week in Dubai.
  • "CHOP has been treating patients worldwide with vascular anomalies for more than 25 years," said Dr. Denise Adams, Director of the Comprehensive Vascular Anomalies Program at Children's Hospital of Philadelphia.
  • "We are thrilled to be showcasing our multidisciplinary expertise and innovation in this field at Arab Health.
  • Arab Health 2024 marks the sixth year that EHS has invited CHOP to exhibit its pediatric innovation alongside EHS colleagues.

CHOP Celebrates Second Anniversary of Middleman Family Pavilion Opening

Retrieved on: 
금요일, 1월 26, 2024
Patient, CHOP, Children's Hospital of Philadelphia, Operating, Medicine, Growth, PICU, Tertiary referral hospital, Hospital, Adolescence, Neonatology

PHILADELPHIA, Jan. 26, 2024 /PRNewswire/ -- Today, Children's Hospital of Philadelphia (CHOP) celebrates the second anniversary of the opening of the Middleman Family Pavilion, CHOP's hospital location in King of Prussia, PA. Since the Middleman Family Pavilion opened in January of 2022, over 130,000 patients have been treated on CHOP's King of Prussia Campus.

Key Points: 
  • -- The Middleman Family Pavilion, CHOP's second inpatient location in King of Prussia, continues to provide families access to more of CHOP's best-in-class care –
    PHILADELPHIA, Jan. 26, 2024 /PRNewswire/ -- Today, Children's Hospital of Philadelphia (CHOP) celebrates the second anniversary of the opening of the Middleman Family Pavilion , CHOP's hospital location in King of Prussia, PA.
  • Since the Middleman Family Pavilion opened in January of 2022, over 130,000 patients have been treated on CHOP's King of Prussia Campus.
  • Staffed 24/7 by a core team of Neonatologists and Advanced Practice Providers, the unit provides comprehensive care with additional non-urgent surgical capabilities.
  • "We are proud and excited about the growth and expansion of services at the Middleman Family Pavilion in the last two years," said Cheryl Gebeline-Myers, Vice President of Operations, Children's Hospital of Philadelphia's Middle Family Pavilion in King of Prussia.

Freedom Mortgage Wraps Up a Solid 2023

Retrieved on: 
월요일, 1월 22, 2024
Dream, Freedom, Toys for Tots, Meal, Hunger, CHOP, Hospital, Social media, Partnership, Housing, Reservist, Children's Hospital of Philadelphia, Friends, Einstein Medical Center Philadelphia, United Service Organizations, Comment, Mortgage Bankers Association, Veteran, Freedom from Hunger, National Guard, Toy, FHA, Backpack, South China Sea raid, Hospice and palliative medicine, The Salvation Army, Feeding America, Federal Housing Administration, USO, Real estate

BOCA RATON, Fla., Jan. 22, 2024 /PRNewswire/ -- Freedom Mortgage, one of the largest full-service independent mortgage companies, and a top VA and top Federal Housing Administration (FHA) (government-insured) lender in the U.S., had a solid 2023, helping nearly 80,000 borrowers secure financing for their most important asset—their homes.

Key Points: 
  • Last year, Freedom Mortgage helped over 50,000 borrowers successfully achieve a better financial position through loan modifications or partial claims.
  • Middleman commended Freedom Mortgage employees for their generosity and dedication to supporting multiple charitable organizations throughout 2023, including programs for veterans, service members, and their families.
  • Additionally, through donations from entries in the Freedom Mortgage Celebrate Freedom Award contest and employees' payroll deduction, over $30,000 was raised for Feeding America.
  • One of the nation's largest independent mortgage companies, Freedom Mortgage is committed to fostering homeownership and financial betterment across the country.